Binding of Wild-Type P53 by Topoisomerase II and Overexpression of Topoisomerase II in Human Hepatocellular Carcinoma
- 1 May 1997
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 234 (1) , 194-197
- https://doi.org/10.1006/bbrc.1997.6539
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Identification of Two p53-Binding Proteins Using a Recombinant Vaccinia Virus Containing the Wild-Type Human p53 GeneBiochemical and Biophysical Research Communications, 1995
- Multiple chromosomal populations of topoisomerase II detected in vivo by time-lapse, three-dimensional wide-field microscopyCell, 1993
- p53 function and dysfunctionCell, 1992
- The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivationCell, 1992
- Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumoursNature, 1992
- p53 immunostaining as a marker of malignant disease in diagnostic cytopathologyThe Lancet, 1991
- DNA TOPOISOMERASE POISONS AS ANTITUMOR DRUGSAnnual Review of Biochemistry, 1989
- The p53 proto-oncogene can act as a suppressor of transformationCell, 1989
- Topoisomerase II: A specific marker for cell proliferation.The Journal of cell biology, 1986
- DNA TOPOISOMERASESAnnual Review of Biochemistry, 1985